TORRID HOLDINGS INC (CURV) Fundamental Analysis & Valuation

NYSE:CURV • US89142B1070

Current stock price

1.8 USD
+0.03 (+1.69%)
Last:

This CURV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CURV Profitability Analysis

1.1 Basic Checks

  • CURV had negative earnings in the past year.
  • CURV had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: CURV reported negative net income in multiple years.
  • CURV had a positive operating cash flow in 4 of the past 5 years.
CURV Yearly Net Income VS EBIT VS OCF VS FCFCURV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 50M 100M 150M

1.2 Ratios

  • With a Return On Assets value of -1.76%, CURV perfoms like the industry average, outperforming 41.46% of the companies in the same industry.
  • CURV's Return On Invested Capital of 8.57% is fine compared to the rest of the industry. CURV outperforms 75.61% of its industry peers.
  • CURV had an Average Return On Invested Capital over the past 3 years of 14.52%. This is in line with the industry average of 13.27%.
  • The 3 year average ROIC (14.52%) for CURV is well above the current ROIC(8.57%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -1.76%
ROE N/A
ROIC 8.57%
ROA(3y)1.34%
ROA(5y)1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)14.52%
ROIC(5y)16.49%
CURV Yearly ROA, ROE, ROICCURV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 20 -20 40 -40 60

1.3 Margins

  • With a Operating Margin value of 2.14%, CURV perfoms like the industry average, outperforming 52.85% of the companies in the same industry.
  • CURV's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 34.79%, CURV perfoms like the industry average, outperforming 47.15% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CURV has remained more or less at the same level.
Industry RankSector Rank
OM 2.14%
PM (TTM) N/A
GM 34.79%
OM growth 3Y-35.26%
OM growth 5Y-18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.83%
GM growth 5Y0.08%
CURV Yearly Profit, Operating, Gross MarginsCURV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CURV Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CURV is creating some value.
  • CURV has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CURV has been reduced compared to 5 years ago.
  • CURV has a worse debt/assets ratio than last year.
CURV Yearly Shares OutstandingCURV Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CURV Yearly Total Debt VS Total AssetsCURV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M

2.2 Solvency

  • CURV has an Altman-Z score of 1.50. This is a bad value and indicates that CURV is not financially healthy and even has some risk of bankruptcy.
  • CURV has a worse Altman-Z score (1.50) than 60.16% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.5
ROIC/WACC0.98
WACC8.73%
CURV Yearly LT Debt VS Equity VS FCFCURV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 100M -100M 200M -200M 300M

2.3 Liquidity

  • CURV has a Current Ratio of 0.78. This is a bad value and indicates that CURV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.78, CURV is not doing good in the industry: 84.55% of the companies in the same industry are doing better.
  • CURV has a Quick Ratio of 0.78. This is a bad value and indicates that CURV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CURV has a Quick ratio of 0.23. This is amonst the worse of the industry: CURV underperforms 82.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.23
CURV Yearly Current Assets VS Current LiabilitesCURV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. CURV Growth Analysis

3.1 Past

  • The earnings per share for CURV have decreased strongly by -137.50% in the last year.
  • CURV shows a decrease in Revenue. In the last year, the revenue decreased by -9.39%.
  • The Revenue has been growing slightly by 0.32% on average over the past years.
EPS 1Y (TTM)-137.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-166.67%
Revenue 1Y (TTM)-9.39%
Revenue growth 3Y-8.09%
Revenue growth 5Y0.32%
Sales Q2Q%-14.3%

3.2 Future

  • Based on estimates for the next years, CURV will show a very strong growth in Earnings Per Share. The EPS will grow by 28.84% on average per year.
  • The Revenue is expected to decrease by -2.72% on average over the next years.
EPS Next Y34.84%
EPS Next 2Y28.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.57%
Revenue Next 2Y-2.72%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CURV Yearly Revenue VS EstimatesCURV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
CURV Yearly EPS VS EstimatesCURV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

1

4. CURV Valuation Analysis

4.1 Price/Earnings Ratio

  • CURV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CURV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CURV Price Earnings VS Forward Price EarningsCURV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

  • CURV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CURV is cheaper than 69.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.44
CURV Per share dataCURV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CURV's earnings are expected to grow with 28.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.84%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CURV Dividend Analysis

5.1 Amount

  • No dividends for CURV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CURV Fundamentals: All Metrics, Ratios and Statistics

TORRID HOLDINGS INC

NYSE:CURV (3/31/2026, 10:16:23 AM)

1.8

+0.03 (+1.69%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-19
Earnings (Next)06-03
Inst Owners24.57%
Inst Owner Change-2.26%
Ins Owners7.43%
Ins Owner Change0.15%
Market Cap178.56M
Revenue(TTM)1.00B
Net Income(TTM)-7.03M
Analysts52.73
Price Target1.61 (-10.56%)
Short Float %12.12%
Short Ratio4.2
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-373.19%
Min EPS beat(2)-781.91%
Max EPS beat(2)35.54%
EPS beat(4)2
Avg EPS beat(4)-190.48%
Min EPS beat(4)-781.91%
Max EPS beat(4)35.54%
EPS beat(8)5
Avg EPS beat(8)-97.64%
EPS beat(12)7
Avg EPS beat(12)-62.37%
EPS beat(16)9
Avg EPS beat(16)-46.11%
Revenue beat(2)1
Avg Revenue beat(2)-0.8%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)0.81%
Revenue beat(4)2
Avg Revenue beat(4)-0.91%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)0.81%
Revenue beat(8)3
Avg Revenue beat(8)-2.02%
Revenue beat(12)5
Avg Revenue beat(12)-0.79%
Revenue beat(16)8
Avg Revenue beat(16)0.24%
PT rev (1m)7.12%
PT rev (3m)7.12%
EPS NQ rev (1m)-62.11%
EPS NQ rev (3m)-65.38%
EPS NY rev (1m)0%
EPS NY rev (3m)-866.6%
Revenue NQ rev (1m)3.06%
Revenue NQ rev (3m)1.13%
Revenue NY rev (1m)-0.59%
Revenue NY rev (3m)-1.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.18
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 7.44
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS10.08
BVpS-2.15
TBVpS-2.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.76%
ROE N/A
ROCE 14.14%
ROIC 8.57%
ROICexc 9.58%
ROICexgc 10.09%
OM 2.14%
PM (TTM) N/A
GM 34.79%
FCFM N/A
ROA(3y)1.34%
ROA(5y)1.67%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)14.52%
ROIC(5y)16.49%
ROICexc(3y)16.74%
ROICexc(5y)18.35%
ROICexgc(3y)17.47%
ROICexgc(5y)19.06%
ROCE(3y)20.96%
ROCE(5y)23.61%
ROICexgc growth 3Y-30.17%
ROICexgc growth 5Y-9.11%
ROICexc growth 3Y-30.61%
ROICexc growth 5Y-9.47%
OM growth 3Y-35.26%
OM growth 5Y-18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.83%
GM growth 5Y0.08%
F-Score2
Asset Turnover2.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 5.1
Cap/Depr 24.52%
Cap/Sales 0.89%
Interest Coverage 0.66
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.23
Altman-Z 1.5
F-Score2
WACC8.73%
ROIC/WACC0.98
Cap/Depr(3y)43.86%
Cap/Depr(5y)48.36%
Cap/Sales(3y)1.48%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-137.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-166.67%
EPS Next Y34.84%
EPS Next 2Y28.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.39%
Revenue growth 3Y-8.09%
Revenue growth 5Y0.32%
Sales Q2Q%-14.3%
Revenue Next Year-5.57%
Revenue Next 2Y-2.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-62.59%
EBIT growth 3Y-40.5%
EBIT growth 5Y-17.73%
EBIT Next Year253.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-134.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-116.81%
OCF growth 3YN/A
OCF growth 5YN/A

TORRID HOLDINGS INC / CURV Fundamental Analysis FAQ

What is the fundamental rating for CURV stock?

ChartMill assigns a fundamental rating of 2 / 10 to CURV.


What is the valuation status for CURV stock?

ChartMill assigns a valuation rating of 1 / 10 to TORRID HOLDINGS INC (CURV). This can be considered as Overvalued.


Can you provide the profitability details for TORRID HOLDINGS INC?

TORRID HOLDINGS INC (CURV) has a profitability rating of 3 / 10.


How financially healthy is TORRID HOLDINGS INC?

The financial health rating of TORRID HOLDINGS INC (CURV) is 1 / 10.